References and selected publications:

References and selected publications:

1.    Marchini, A., Scott, E. M., and Rommelaere, J. (2016) Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade. Viruses 8
2.    Marchini, A., Bonifati, S., Scott, E. M., Angelova, A. L., and Rommelaere, J. (2015) Oncolytic parvoviruses: from basic virology to clinical applications. Virol J 12, 6
3.    Nuesch, J. P., Lacroix, J., Marchini, A., and Rommelaere, J. (2012) Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment. Clin Cancer Res 18, 3516-3523
4.    Allaume, X., El-Andaloussi, N., Leuchs, B., Bonifati, S., Kulkarni, A., Marttila, T., Kaufmann, J. K., Nettelbeck, D. M., Kleinschmidt, J., Rommelaere, J., and Marchini, A. (2012) Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. J Virol 86, 3452-3465
5.    El-Andaloussi, N., Bonifati, S., Kaufmann, J. K., Mailly, L., Daeffler, L., Deryckere, F., Nettelbeck, D. M., Rommelaere, J., and Marchini, A. (2012) Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential. J Virol 86, 10418-10431
6.    Illarionova, A., Rommelaere, J., Leuchs, B., and Marchini, A. ( 2014) Modified parvovirus useful for gene silencing. European Patent EP2620503
7.    Li, J., Schroeder, L., Geletneky, K., Rommelaere, J., and Marchini, A. (2016) Cancer therapy with a parvovirus combined with inhibitors of the anti-apoptotic Bcl-2 proteins. European Patent EP3024491
8.    Li, J., Bonifati, S., Hristov, G., Marttila, T., Valmary-Degano, S., Stanzel, S., Schnolzer, M., Mougin, C., Aprahamian, M., Grekova, S. P., Raykov, Z., Rommelaere, J., and Marchini, A. (2013) Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Mol Med 5, 1537-1555
9.    Hristov, G., Kramer, M., Li, J., El-Andaloussi, N., Mora, R., Daeffler, L., Zentgraf, H., Rommelaere, J., and Marchini, A. (2010) Through Its Nonstructural Protein NS1, Parvovirus H-1 Induces Apoptosis via Accumulation of Reactive Oxygen Species. J Virol 84, 5909-5922


Further reading

Interview to Antonio Marchini:  Advances in the development of parvovirus-based anti-cancer therapies Cell Gene Therapy Insights 2017; 3(2),125-130

 

to top